Medical Science Monitor · 2018 · 47 citations · 32 references
MedicineCardiologyClinical CardiologyLipid BiochemistryPreventive CardiologyAtrial FibrillationCardiac BiomarkersCardiovascular AssessmentCardiovascular DiseaseLipid DisordersAtrial Fibrillation BiomarkersCardiovascular Disease PrevalenceComprehensive Metabolic PanelHepatic Function TestsHigh-density Lipoprotein Cholesterol MeasurementLipid Profile AnalysisLow-density Lipoprotein Cholesterol MeasurementRenal Function Covariates
BACKGROUND Dyslipidemia is the most frequent comorbidity in patients with cardiovascular disease. However, studies examining the relationship between blood lipid profiles and AF have produced inconsistent results. MATERIAL AND METHODS A total of 651 patients were enrolled into 3 groups: Healthy controls (n=64), Paroxysmal AF (PAF; n=270), and Continuous AF (CAF; n=317). All enrolled patients underwent routine baseline 12-lead electrocardiography (ECG) and 24-h dynamic ECG along with blood testing, which included the following: complete metabolic panel, hepatic function, renal function, circulating thyroxine, fasting high-density lipoprotein cholesterol (HDL -C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and total cholesterol (TC). RESULTS Patients with AF had significantly higher levels of triglycerides (TG), lower levels of LDL-C-c, and lower levels of HDL-C (p<0.05). TC (OR 0.979, p<0.9247) and TG (OR 0.945, p<0.6496) were negatively and linearly associated with PAF, while TG (OR 0.807, p=0.2042), LDL-C (OR 0.334, p=0.0036), and HDL-C (OR 0.136, p=0.0002) were negatively and linearly associated with CAF. CONCLUSIONS Compared to healthy controls, patients with AF had lower blood lipid levels, especially LDL-c and HDL-c levels. Hypolipoproteinemia may increase patient susceptibility to developing AF.
32
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
James Shepherd, Stuart M. Cobbe, Ian Ford et al. · New England Journal of Medicine · 1995 · 7.5K citations · Full text
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Valentı́n Fuster, Lars Rydén, David S. Cannom et al. · Circulation · 2006 · 2.8K citations · Full text
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
Yoko Miyasaka, Marion E. Barnes, Bernard J. Gersh et al. · Circulation · 2006 · 2.6K citations · Full text